Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant
- Conditions
- Meniscus; DegenerationOsteoarthritis, Knee
- Interventions
- Device: NUsurface Meniscus Implant
- Registration Number
- NCT01712191
- Lead Sponsor
- Active Implants
- Brief Summary
This is a prospective, multi-center, open label, non-randomized study, evaluating the treating of medial meniscus deficiency with the NUsurface Meniscus Implant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 128
- Have a degenerative and/or torn meniscus and/or previous meniscectomy as confirmed by diagnostic MRI.
- Have a pain score of 75 or less on the KOOS pain scale, with 100 being normal.
- Be in neutral alignment +/- 5 degrees of the mechanical axis.
- Be between age 35 and 75 at the time of the planned surgery.
- Be able to be fitted anatomically with a size 30 to 90 NUsurface® device.
- Have a normal mental status.
- Be willing and able to attend all follow up visits, complete all study questionnaires, and undergo required X-ray and MRI schedule.
- Be able and willing to understand and sign the informed consent form.
- Have evidence of a Grade IV articular cartilage loss on the medial tibial plateau or femoral condyle that could contact the NUsurface implant
- Have lateral compartment pain with lateral articular cartilage damage greater than Grade II (OB), and/or a lateral meniscus tear(s)
- Have a varus or valgus knee deformity > 5 degrees.
- Have a laxity level of more than II (ICRS), secondary to previous injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL).
- Have patella instability or non-anatomically positioned patella
- Have patellar compartment pain and/or patellar articular cartilage damage greater than Grade II (OB).
- Need a tibial osteotomy at the time of surgery.
- Have an ACL reconstruction performed less than 9 months before implanting the NUsurface® device
- Have any type of previously implanted prosthetic meniscus or ligament or knee implant made of plastic.
- Have a knee flexion contracture > 10 degrees
- Be unable to flex the knee to 90 degrees
- Have a leg length discrepancy causing a noticeable limp.
- Have had a previous major knee condyle surgery
- Present with insufficiency fractures or avascular necrosis of the medial compartment.
- Have an active infection or tumor.
- Have any type of knee joint inflammatory disease including Sjogren's syndrome.
- Have neuropathic knee osteoarthropathy, also known as Charcot joint.
- Have any medical condition that does not allow arthroscopy at the point of entry to the knee.
- Be pregnant or is a female intending to become pregnant during the study period.
- Be mentally incapacitated.
- Be a prisoner.
- Be a patient who has economic incentive not to improve (e.g., workman's compensation patient)
- Be morbidly Obese (BMI > 35).
- Is unwilling or unable to have an X-ray, Fluro, or MRI of the affected knee
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description NUsurface Meniscus Implant NUsurface Meniscus Implant -
- Primary Outcome Measures
Name Time Method Knee injury and Osteoarthritis Outcome Score (KOOS) 24 Months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (10)
Ghent University Hospital
🇧🇪Ghent, Belgium
Emek Medical Center
🇮🇱Afula, Israel
Tel Aviv Sourasky Medical Center- Ichilov
🇮🇱Tel Aviv, Israel
Maastricht University Medical Centre
🇳🇱Maastricht, Netherlands
AZ Monica
🇧🇪Antwerpen, Belgium
UniKlinikum Regensburg
🇩🇪Regensburg, Germany
Sporthopaedicum Berlin
🇩🇪Berlin, Germany
Assaf Harofeh Medical Center
🇮🇱Zerifin, Israel
Sacro Cuore- Don Calabria Hospital
🇮🇹Negrar, Italy
Sahlgrenska universitetssjukhuset
🇸🇪Göteborg, Sweden